Food naturally boosts your body’s GLP-1 levels, explained Dr. Sun Kim, an endocrinologist at Stanford Health Care in ...

"Oral GLP-1 receptor agonist Rybelsus reduces risk of cardiovascular events in type 2 diabetes patients" was originally ...

With weight loss injectables like Ozempic and Mounjaro taking the world by storm, the diet industry is seemingly being left ...

GLP-1 receptor agonists and SGLT2 inhibitors were both initially approved for type 2 diabetes. But over the last several ...

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

GLP-1 receptor agonists do not affect cardiovascular, kidney, or safety outcomes regardless of SGLT2 inhibitor use in patients with type 2 diabetes.

New guidelines for stroke prevention from the American Stroke Association highlight unique risk factors for women and how ...

The American Stroke Association has released new guidelines to lower your risk of stroke. Here’s what the organization ...

Hims & Hers is taking a more serious approach to its latest campaign. The telehealth company, which is best known for its ...

Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do ...

Weight loss can be a challenging journey, especially when seeking effective and accessible solutions. The rise in popularity ...